Lumexa Imaging has formed a strategic joint venture with Hospital for Special Surgery to expand outpatient imaging services in the New York City metro area.
The agreement marks Lumexa’s 9th joint venture and strengthens the company’s presence in New York, according to the announcement.
Lumexa and HSS said they plan to expand access to advanced outpatient imaging services across the region.
The companies are also evaluating future outpatient imaging locations in the New York market as part of Lumexa’s long-term expansion plans.
The joint venture will use HSS’s subspecialized radiology expertise and Lumexa’s outpatient imaging operating model, according to the announcement.
“Lumexa Imaging stood out for its proven joint venture model,” Bryan T. Kelly, MD, MBA, president and CEO of HSS, said in the announcement.
Lumexa said its broader growth strategy includes de novo development, acquisitions, and strategic joint ventures with health systems.
The company operates more than 190 outpatient imaging centers and has more than 5,000 team members. It said its network performed about 4M outpatient procedures systemwide in 2025.
In May, Lumexa said 2 of its 4 newly added imaging locations in 2026 came through acquisitions with joint venture partners Advocate Health and UPMC.
HSS is an academic medical center focused on musculoskeletal health. The announcement said HSS was ranked No. 1 in orthopedics by U.S. News & World Report for 2025-2026.
Company:Lumexa
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
